CORRESP Filing
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Date: June 26, 2025 · CIK: 0001335105 · Accession: 0001641172-25-016613
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288120
Letter
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
East Colorado Boulevard, Suite 180
Pasadena, California 91101
June 26, 2025
VIA EDGAR
Securities and Exchange Commission Division of Corporation Finance
F. Street, N.E.
Washington, D.C. 20549
Re: Lixte Biotechnology Holdings, Inc.
Registration Statement on Form S-1
File No. 333-288120
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on June 24,2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday June 26, 2025 at 5:00 p.m. Eastern Time in accordance with Rule 461 under the Securities Act of 1933, as amended, We are no longer requesting that the Registration Statement be declared effective at this time and we are hereby formally withdrawing our request for acceleration of the effective date. Please call our counsel, David Ficksman of TroyGould PC at 818 469 4200 if you have any questions.
Very
truly yours,
LIXTE
BIOTECHNOLOGY HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm LIXTE BIOTECHNOLOGY HOLDINGS, INC. 680 East Colorado Boulevard, Suite 180 Pasadena, California 91101 June 26, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Lixte Biotechnology Holdings, Inc. Registration Statement on Form S-1 File No. 333-288120 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on June 24,2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday June 26, 2025 at 5:00 p.m. Eastern Time in accordance with Rule 461 under the Securities Act of 1933, as amended, We are no longer requesting that the Registration Statement be declared effective at this time and we are hereby formally withdrawing our request for acceleration of the effective date. Please call our counsel, David Ficksman of TroyGould PC at 818 469 4200 if you have any questions. Very truly yours, LIXTE BIOTECHNOLOGY HOLDINGS, INC. By: /s/ Geordan Pursglove Geordan Pursglove Chief Executive Officer